QuantHealth
AI-driven platform that simulates clinical trials to predict outcomes before patient enrollment
$45MSeries B
Role not disclosedActivity from announced rounds
AI-driven platform that simulates clinical trials to predict outcomes before patient enrollment
AdvanCell develops targeted alpha radiopharmaceuticals for cancer using Lead-212, with integrated isotope supply and manufacturing.
Bionyra Pharma develops biologic therapies for severe immunological and inflammatory diseases.
Builds AI platform helping pharma companies identify, activate and optimize patient and HCP audiences
Develops therapies for neurodegenerative diseases.